Get the Stockscreener App
1.32
1.54%
0.02
After Hours:
1.35
0.03
+2.27%
Opko Health Inc stock is traded at $1.32, with a volume of 3.26M.
It is up +1.54% in the last 24 hours and down -10.81% over the past month.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
See More
Previous Close:
$1.30
Open:
$1.3
24h Volume:
3.26M
Relative Volume:
1.45
Market Cap:
$1.01B
Revenue:
$711.41M
Net Income/Loss:
$-133.73M
P/E Ratio:
-6.9474
EPS:
-0.19
Net Cash Flow:
$-199.99M
1W Performance:
+3.13%
1M Performance:
-10.81%
6M Performance:
+1.54%
1Y Performance:
-15.38%
1-Day Range:
$1.29
$1.34
1-Week Range:
$1.24
$1.35
52-Week Range:
$1.11
$2.035
Opko Health Inc Stock (OPK) Company Profile
Name
Opko Health Inc
Sector
Industry
Phone
305-575-4181
Address
4400 BISCAYNE BLVD., MIAMI, FL
Compare OPK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OPK
Opko Health Inc
|
1.32 | 998.01M | 711.41M | -133.73M | -199.99M | -0.19 |
|
TMO
Thermo Fisher Scientific Inc
|
587.48 | 215.18B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
227.39 | 156.94B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
725.91 | 55.05B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
151.25 | 41.12B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
224.90 | 36.97B | 15.90B | 1.28B | 2.21B | 7.2842 |
Opko Health Inc Stock (OPK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-20-25 | Initiated | JP Morgan | Neutral |
| Oct-31-25 | Downgrade | Jefferies | Buy → Hold |
| Apr-25-25 | Initiated | JP Morgan | Neutral |
| Jun-29-23 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Dec-15-22 | Initiated | H.C. Wainwright | Buy |
| Jan-24-22 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Jun-21-21 | Initiated | Ladenburg Thalmann | Buy |
| Nov-25-19 | Initiated | Piper Jaffray | Overweight |
| Mar-02-18 | Downgrade | JP Morgan | Neutral → Underweight |
| Sep-14-17 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-21-16 | Reiterated | Standpoint Research | Buy |
| Jun-03-16 | Initiated | Standpoint Research | Buy |
| Mar-31-16 | Reiterated | Barrington Research | Outperform |
| Oct-16-15 | Initiated | JP Morgan | Overweight |
| Sep-11-15 | Downgrade | Jefferies | Buy → Hold |
| Mar-03-15 | Downgrade | Oppenheimer | Outperform → Perform |
| May-12-14 | Reiterated | Oppenheimer | Outperform |
| Mar-14-14 | Initiated | Oppenheimer | Outperform |
| Nov-13-13 | Reiterated | Ladenburg Thalmann | Buy |
| May-30-13 | Reiterated | Ladenburg Thalmann | Buy |
| Oct-22-12 | Initiated | Barrington Research | Outperform |
| Dec-01-11 | Reiterated | Ladenburg Thalmann | Buy |
| Jul-14-11 | Initiated | Ladenburg Thalmann | Buy |
View All
Opko Health Inc Stock (OPK) Latest News
OPKO Health (NASDAQ:OPK) CEO Acquires $771,400.00 in Stock - MarketBeat
Zacks Research Boosts Earnings Estimates for OPKO Health - MarketBeat
OPKO Health (NASDAQ:OPK) Earns Neutral Rating from Analysts at JPMorgan Chase & Co. - MarketBeat
Will OPKO Health Inc. (XCY) stock attract long term capital inflowsJuly 2025 Summary & Daily Price Action Insights - newser.com
OPKO Health (NASDAQ:OPK) CEO Phillip Md Et Al Frost Purchases 580,000 Shares - MarketBeat
JPMorgan initiates Opko Health stock with Neutral rating By Investing.com - Investing.com Canada
OPKO Health (OPK): Evaluating Valuation After Insider Buying and Sales Concerns on Ngenla - Yahoo Finance
Is OPKO Health Inc. building a consolidation baseWeekly Gains Summary & Fast Exit and Entry Trade Guides - newser.com
Why pension funds invest in OPKO Health Inc. (XCY) stock2025 Year in Review & Fast Gain Stock Trading Tips - newser.com
Phillip Md Et Al Frost Purchases 533,300 Shares of OPKO Health (NASDAQ:OPK) Stock - MarketBeat
Opko Health Insider Bought Shares Worth $759,115, According to a Recent SEC Filing - MarketScreener
Regression analysis insights on OPKO Health Inc. performanceDay Trade & Daily Profit Focused Screening - newser.com
OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference - The Manila Times
Is OPKO Health Inc. stock supported by strong fundamentalsWeekly Profit Summary & Low Risk High Win Rate Picks - newser.com
How reliable is OPKO Health Inc. (XCY) stock dividend growthGDP Growth & Reliable Intraday Trade Plans - newser.com
Will OPKO Health Inc. (XCY) stock benefit from Fed rate cuts2025 Bull vs Bear & Momentum Based Trading Signals - newser.com
Why analysts remain bullish on OPKO Health Inc. stockWall Street Watch & Stock Portfolio Risk Control - newser.com
Using Bollinger Bands to evaluate OPKO Health Inc.Recession Risk & Long-Term Capital Growth Strategies - newser.com
Opko Health Insider Bought Shares Worth $737,748, According to a Recent SEC Filing - MarketScreener
News impact scoring models applied to OPKO Health Inc.Market Performance Report & Weekly Breakout Opportunity Watchlist - newser.com
How OPKO Health Inc. (XCY) stock performs during market turbulence2025 Macro Impact & Verified Momentum Watchlists - newser.com
Will OPKO Health Inc. stock see insider buyingQuarterly Trade Report & Step-by-Step Swing Trade Plans - newser.com
Risk vs reward if holding onto OPKO Health Inc.Gold Moves & Low Drawdown Trading Strategies - newser.com
Opko Health CEO Phillip Frost buys $737,747 in OPK stock By Investing.com - Investing.com Nigeria
Opko Health CEO Phillip Frost buys $737,747 in OPK stock - Investing.com
Opko Health Insider Bought Shares Worth $678,906, According to a Recent SEC Filing - MarketScreener
Will OPKO Health Inc. stock benefit from green energy trendsJuly 2025 Snapshot & Daily Profit Focused Screening - newser.com
Entera Bio to Participate in the 8th Annual Evercore ISI Healthcare Conference - GlobeNewswire Inc.
Will OPKO Health Inc. (XCY) stock beat growth indexesM&A Rumor & Technical Entry and Exit Alerts - newser.com
OPKO Health, Inc. $OPK Shares Sold by Y.D. More Investments Ltd - MarketBeat
Top chart patterns to watch in OPKO Health Inc.Bull Run & Low Drawdown Investment Ideas - newser.com
Is OPKO Health Inc. stock gaining market shareJuly 2025 Closing Moves & High Return Stock Watch Alerts - newser.com
Can technical indicators confirm OPKO Health Inc.’s reversalInsider Buying & Stepwise Trade Signal Guides - newser.com
Opko Health Inc Stock (OPK) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):